logo

For the Inventor, By the Inventor

Tel Aviv, Israel

Moshe M Werber

USPTO Granted Patents = 13

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 111(Granted Patents)


Company Filing History:

goldMedal12 out of 67 
 
Bio-technology General Corporation
 patents
silverMedal1 out of 13 
 
Savient Pharmaceuticals, Inc.
 patents

Years Active: 1993-2006

Loading Chart...
13 patents (USPTO):Explore Patents
1. 7087722 - Fibrin binding domain polypeptides and uses and methods of producing same (2006-08-08),
2. 6211341 - Polypeptide having factor Xa inhibitory activity (2001-04-03),
3. 6121426 - Fibrin binding domain polypeptides and uses and methods of producing same (2000-09-19),
4. 5965383 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-10-12),
5. 5869616 - Fibrin binding domain polypeptides and uses and methods of producing same (1999-02-09),
6. 5863534 - Polypeptide having factor Xa inhibitory method of reducing blood (1999-01-26),
7. 5858970 - Polypeptide having Factor Xa inhibitory activity (1999-01-12),
8. 5824641 - Method of treating of preventing influenza (1998-10-20),
9. 5801017 - Production of recombinant factor Xa inhibitor of leech Hirudo (1998-09-01),
10. 5783421 - DNA encoding novel polypeptide having Factor Xa inhibitory activity (1998-07-21),
11. 5679320 - Fibrin binding domain polypeptides and uses and methods of producing same (1997-10-21),
12. 5455158 - Fibrin binding domain polypeptides and uses and methods of producing same (1995-10-03),
13. 5270030 - Fibrin binding domain polypeptide and method of producing (1993-12-14),

Title: Moshe M Werber: Innovator in Biopharmaceuticals

Introduction

Moshe M Werber is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biopharmaceuticals, holding a total of 13 patents. His work primarily focuses on polypeptides and their applications in medical imaging and treatment.

Latest Patents

One of his latest patents is titled "Fibrin binding domain polypeptides and uses and methods of producing same." This invention provides an imaging agent that comprises a polypeptide labeled with an imageable marker. The polypeptide has an amino acid sequence substantially present in the fibrin binding domain of naturally-occurring human fibronectin and is capable of binding to fibrin. The invention also includes methods for imaging fibrin-containing substances, such as thrombus or atherosclerotic plaque. Additionally, it provides plasmids for the expression of these polypeptides, methods of treatment using them, and methods for recovering and refolding the polypeptides.

Another notable patent is related to a polypeptide having factor Xa inhibitory activity. This invention provides an antibody that specifically reacts with an epitope of a polypeptide comprising a specific amino acid sequence. The patent also includes a monoclonal antibody as described.

Career Highlights

Throughout his career, Moshe M Werber has worked with several notable companies, including Biotechnology General Corporation and Savient Pharmaceuticals, Inc. His expertise in biopharmaceuticals has allowed him to contribute to various innovative projects and advancements in the field.

Collaborations

Some of his notable coworkers include Avigdor Levanon and Rachel Guy. Their collaboration has likely contributed to the success of various projects and patents in which Werber has been involved.

Conclusion

Moshe M Werber is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in medical imaging and treatment. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…